TCL Archive Bertagnolli: Why Brigham Stopped Making Morcellation Available Outside Of A Registry Trial July 4, 2014
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006